Positive test for Bayer deep vein thrombosis drug
The two dose-finding studies included more than 1,300 patients and demonstrated safety and efficacy for BAY 59-7939 similar to the current gold standard enoxaparin, a low molecular weight
China-based Biocytogen Pharmaceuticals has entered a non-exclusive licensing agreement with Qilu Pharmaceutical for a fully human VHH antibody molecule.